🎉 M&A multiples are live!
Check it out!

Xtant Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Xtant Medical and similar public comparables like Myomo, InfuSystem, and SmartVest.

Xtant Medical Overview

About Xtant Medical

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.


Founded

2006

HQ

United States of America
Employees

232

Financials

LTM Revenue $120M

LTM EBITDA $2.3M

EV

$84.6M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Xtant Medical Financials

Xtant Medical has a last 12-month revenue of $120M and a last 12-month EBITDA of $2.3M.

In the most recent fiscal year, Xtant Medical achieved revenue of $117M and an EBITDA of -$7.9M.

Xtant Medical expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Xtant Medical valuation multiples based on analyst estimates

Xtant Medical P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $91.3M $117M XXX XXX XXX
Gross Profit $32.1M $55.5M XXX XXX XXX
Gross Margin 35% 47% XXX XXX XXX
EBITDA $5.1M -$7.9M XXX XXX XXX
EBITDA Margin 6% -7% XXX XXX XXX
Net Profit -$8.5M $0.7M XXX XXX XXX
Net Margin -9% 1% XXX XXX XXX
Net Debt n/a $16.1M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Xtant Medical Stock Performance

As of April 15, 2025, Xtant Medical's stock price is $0.

Xtant Medical has current market cap of $55.6M, and EV of $84.6M.

See Xtant Medical trading valuation data

Xtant Medical Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$84.6M $55.6M XXX XXX XXX XXX $-0.10

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Xtant Medical Valuation Multiples

As of April 15, 2025, Xtant Medical has market cap of $55.6M and EV of $84.6M.

Xtant Medical's trades at 0.7x LTM EV/Revenue multiple, and 36.4x LTM EBITDA.

Analysts estimate Xtant Medical's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Xtant Medical and 10K+ public comps

Xtant Medical Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $84.6M XXX XXX XXX
EV/Revenue 0.7x XXX XXX XXX
EV/EBITDA -10.7x XXX XXX XXX
P/E -3.4x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -5.3x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Xtant Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Xtant Medical Valuation Multiples

Xtant Medical's NTM/LTM revenue growth is 8%

Xtant Medical's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.3M for the same period.

Over next 12 months, Xtant Medical's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Xtant Medical's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Xtant Medical and other 10K+ public comps

Xtant Medical Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 28% XXX XXX XXX XXX
EBITDA Margin -7% XXX XXX XXX XXX
EBITDA Growth -255% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 2% XXX XXX XXX XXX
Revenue per Employee $0.5M XXX XXX XXX XXX
Opex per Employee $0.3M XXX XXX XXX XXX
S&M Expenses to Revenue 42% XXX XXX XXX XXX
G&A Expenses to Revenue 24% XXX XXX XXX XXX
R&D Expenses to Revenue 2% XXX XXX XXX XXX
Opex to Revenue 68% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Xtant Medical Public Comps

See public comps and valuation multiples for Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Xtant Medical M&A and Investment Activity

Xtant Medical acquired  XXX companies to date.

Last acquisition by Xtant Medical was  XXXXXXXX, XXXXX XXXXX XXXXXX . Xtant Medical acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Xtant Medical

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Xtant Medical

When was Xtant Medical founded? Xtant Medical was founded in 2006.
Where is Xtant Medical headquartered? Xtant Medical is headquartered in United States of America.
How many employees does Xtant Medical have? As of today, Xtant Medical has 232 employees.
Who is the CEO of Xtant Medical? Xtant Medical's CEO is Mr. Sean E. Browne.
Is Xtant Medical publicy listed? Yes, Xtant Medical is a public company listed on ASE.
What is the stock symbol of Xtant Medical? Xtant Medical trades under XTNT ticker.
When did Xtant Medical go public? Xtant Medical went public in 2007.
Who are competitors of Xtant Medical? Similar companies to Xtant Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of Xtant Medical? Xtant Medical's current market cap is $55.6M
What is the current revenue of Xtant Medical? Xtant Medical's last 12-month revenue is $120M.
What is the current EBITDA of Xtant Medical? Xtant Medical's last 12-month EBITDA is $2.3M.
What is the current EV/Revenue multiple of Xtant Medical? Current revenue multiple of Xtant Medical is 0.7x.
What is the current EV/EBITDA multiple of Xtant Medical? Current EBITDA multiple of Xtant Medical is 36.4x.
What is the current revenue growth of Xtant Medical? Xtant Medical revenue growth between 2023 and 2024 was 28%.
Is Xtant Medical profitable? Yes, Xtant Medical is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.